The Impact of Menopausal Hormone Therapy on Liver and Biliary Tract Health
Open Access
- 13 August 2025
- journal article
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 35 (3) , 104-113
Abstract
Aim: to provide summarized data on the relationship between menopausal hormone therapy (MHT) and liver health.Key points. A decrease in estrogen production during the menopausal transition and a deficiency of estrogen and progesterone during postmenopause significantly affect lipid and carbohydrate metabolism and can lead to impaired liver function. With age, the risk of developing metabolic-associated fatty liver disease (MAFLD) in women increases significantly, due to a combination of hormonal changes, a higher incidence of metabolic disorders, and age-related factors. In turn, MAFLD is associated with an increased risk of cardiovascular disease, diabetes mellitus and metabolic disorders. In the absence of well-timed hormonal support, postmenopausal women are at high risk of developing serious complications, therefore, it is extremely important to select MHT with a favorable efficacy and safety profile. The approach to prescribing MHT should take into account the patient’s medical history, individual characteristics, as well as the mode of drug administration, considering the minimum effective dose.Conclusion. Oral combination MHT provides positive metabolic effects through the first-pass metabolism but is not associated with additional health risks.Keywords
This publication has 57 references indexed in Scilit:
- Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic reviewArchives of Gynecology and Obstetrics, 2022
- Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver diseaseHormones, 2022
- Risk of cardiovascular disease and loss in life expectancy in NAFLDHepatology, 2022
- Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research GapsHepatology, 2019
- Molecular pathways of nonalcoholic fatty liver disease development and progressionCellular and Molecular Life Sciences, 2018
- Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific MortalityJAMA, 2017
- Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized TrialsJAMA, 2013
- Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical ImplicationsHepatology, 2010
- New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- Effect of Estrogen Therapy on Gallbladder DiseaseJAMA, 2005